No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009

Emerging Infectious Diseases

Volumn 18, Issue 5, 2012, Pages 801-810

  Mahmud, Salaheddin M ^a,b   van Caeseele, Paul ^a,c   Hammond, Gregory ^a   Kurbis, Carol ^b   Hilderman, Tim ^a,d   Elliott, Lawrence ^a,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

^c CADHAM PROVINCIAL LABORATORY   (Canada)

^d Manitoba Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INSULIN DERIVATIVE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PNEUMOCOCCUS POLYSACCHARIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SIALIDASE INHIBITOR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PANDEMIC; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MANITOBA; MIDDLE AGED; PANDEMICS; YOUNG ADULT;

EID: 84859855512     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1805.111596     Document Type: Article

References (40)

1. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7:e1000258. http://dx.doi.org/10.1371/journal.pmed.1000258
2. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ. 2009;339:b3928. http://dx.doi.org/10.1136/bmj.b3928
3. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374:2072-9. http://dx.doi.org/10.1016/S0140-6736(09)61638-X
4. Carcione D, Giele C, Goggin LS, Kwan KS, Smith DW, Dowse GK, et al. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Euro Surveill. 2010;15:pii:19616.
5. Kelly HA, Grant KA, Fielding JE, Carville KS, Looker CO, Tran T, et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine. 2011;29:6419-26. http://dx.doi.org/10.1016/j.vaccine.2011.03.055
6. Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine. 2011;29:2613-8. http://dx.doi.org/10.1016/j.vaccine.2011.01.046
7. Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine. 2010;28:7460-7. http://dx.doi.org/10.1016/j.vaccine.2010.09.042
8. Larrauri A, Savulescu C, Jiménez-Jorge S, Pérez-Breña P, Pozo F, Casas I, et al. Influenza pandemic (H1N1) 2009 activity during summer 2009: effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Gac Sanit. 2011;25:23-8. http://dx.doi.org/10.1016/j.gaceta.2010.06.010
9. Iuliano AD, Reed C, Guh A, Desai M, Dee D, Kutty P, et al. Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis. 2009;49:1811-20. http://dx.doi.org/10.1086/649555
10. Centers for Disease Control and Prevention. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)-United States, May-June 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1241-5.
11. Lessler J, Reich NG, Cummings DAT. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med. 2009;361:2628-36. http://dx.doi.org/10.1056/NEJMoa0906089
12. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-52. http://dx.doi.org/10.1056/NEJMoa0906453
13. Lee VJ, Tay JK, Chen MIC, Phoon M, Xie M, Wu Y, et al. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine. 2010;28:6852-7. http://dx.doi.org/10.1016/j.vaccine.2010.08.031
14. Pascua PNQ, Song MS, Lee JH, Park KJ, Kwon H, Baek YH, et al. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS ONE. 2009;4:e8431. http://dx.doi.org/10.1371/journal.pone.0008431
15. Loeb M, Earn DJ, Smieja M, Webby R. Pandemic (H1N1) 2009 risk for nurses after trivalent vaccination. Emerg Infect Dis. 2010;16:719-20.
16. Chen MIC, Lee VJM, Lim WY, Barr IG, Lin RTP, Koh GCH, et al. 2009 Influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010;303:1383-91. http://dx.doi.org/10.1001/jama.2010.404
17. Kelly H, Barry S, Laurie K, Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill. 2010;15:pii:19722.
18. Glezen WP. How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Clin Infect Dis. 2010;51:1380-2. http://dx.doi.org/10.1086/657312
19. Embree J. Pandemic 2009 (A)H1N1 influenza (swine flu)-the Manitoba experience. Biochem Cell Biol. 2010;88:589-93. http://dx.doi.org/10.1139/O10-025
20. Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ. 2010;182:349-55. http://dx.doi.org/10.1503/cmaj.091823
21. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS) [in French]. Can Commun Dis Rep. 2008;34(ACS-3):1-46.
22. LeBlanc JJ, Li Y, Bastien N, Forward KR, Davidson RJ, Hatchette TF. Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus. J Clin Microbiol. 2009;47:3805-13. http://dx.doi.org/10.1128/JCM.01344-09
23. Roberts JD, Poffenroth LA, Roos LL, Bebchuk JD, Carter AO. Monitoring childhood immunizations: a Canadian approach. Am J Public Health. 1994;84:1666-8. http://dx.doi.org/10.2105/AJPH.84.10.1666
24. Martens PJ, Frohlich N, Carriere KC, Derksen S, Brownell M. Embedding child health within a framework of regional health: population health status and sociodemographic indicators. Can J Public Health. 2002;93(Suppl 2):S15-20.
25. Lix L, Yogendran M, Burchill C, Metge C, McKeen N, Moore D, et al. Defining and validating chronic diseases: an administrative data approach. Winnipeg (Manitoba, Canada): Manitoba Centre for Health Policy; 2006.
26. Hardy JR, Holford TR, Hall GC, Bracken MB. Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2004;13:749-59. http://dx.doi.org/10.1002/pds.935
27. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ. 2010;182:257-64. http://dx.doi.org/10.1503/cmaj.091884
28. Dupont WD. Power calculations for matched case-control studies. Biometrics. 1988;44:1157-68. http://dx.doi.org/10.2307/2531743
29. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science. 2009;325:197-201. http://dx.doi.org/10.1126/science.1176225
30. Cowling BJ, Ng S, Ma ESK, Cheng CKY, Wai W, Fang VJ, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis. 2010;51:1370-9. http://dx.doi.org/10.1086/657311
31. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, Crowcroft NS, Rosella LC. Seasonal vaccine and H1N1. Selection bias explains seasonal vaccine's protection. BMJ. 2009;339:b4972. http://dx.doi.org/10.1136/bmj.b4972
32. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, Crowcroft NS, Rosella LC. Seasonal vaccine effectiveness against pandemic A/H1N1 [letter]. Lancet. 2010;375:801-2. http://dx.doi.org/10.1016/S0140-6736(10)60338-8
33. Echevarría-Zuno S, Mejía-Aranguré JM, Grajales-Muñiz C, Gonzalez-Bonilla C, Borja-Aburto VH. Seasonal vaccine effectiveness against pandemic A/H1N1 [letter]. Lancet. 2010;375: 802-3. http://dx.doi.org/10.1016/S0140-6736(10)60339-X
34. Johns MC, Eick AA, Blazes DL, Lee S, Perdue CL, Lipnick R, et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS ONE. 2010;5:e10722. http://dx.doi.org/10.1371/journal.pone.0010722
35. Crum-Cianflone NF, Blair PJ, Faix D, Arnold J, Echols S, Sherman SS, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis. 2009;49:1801-10. http://dx.doi.org/10.1086/648508
36. Savitz DA. Interpreting epidemiologic evidence: strategies for study design and analysis. Oxford (New York): Oxford University Press; 2003.
37. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies: I. principles. Am J Epidemiol. 1992;135:1019-28.
38. Statistics Canada. Table 105-0501. Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2007 boundaries) and peer groups, occasional, CANSIM (database). 2011 [cited 2011 Apr 17]. http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=1050501&paSer=&pattern=&stByVal=1&p1=1&p2=-1&tabMode=dataTable&csid=
39. Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease: comparing administrative data and self-reports. Med Care. 1997;35:932-47. http://dx.doi.org/10.1097/00005650-199709000-00006
40. Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26:546-50. http://dx.doi.org/10.1007/s11606-010-1609-1